ХОНДРОИТИНСУЛЬФАТЫ И ИХ РОЛЬ В ОБМЕНЕ ХОНДРОЦИТОВ И МЕЖКЛЕТОЧНОГО МАТРИКСА ХРЯЩЕВОЙ ТКАНИ

1. <div><p>Алексеева Л.И., Беневоленская Л.И., Насонов Е.Л. и соавт. Структум (хондроитин сульфат) - новый терапевтический препарат для лечения остеоартроза. Тер. архив, 1999, 71,5, 51-53.</p><p>Мусил Я., Новакова О., Кунц К. Современная биохимия в схемах. 1984, М., Мир, 215.</p><p>Никитин В.Н., Перский Е.Э., Утевская Л.А. Возрастная и эволюционная биохимия кол- лагеновых структур. Киев, Наукова Думка, 1977, 242.</p><p>Павлова В.Н., Копьева Т.Н., Слуцкий Л.П., Павлов Г.Г. Хрящ. М., Медицина. 1988, 317.</p><p>Панасюк А.Ф., Ярошук Г.В., Митровнч Д. Влияние свободных радикалов на пролиферацию и обмен хондроцитов и на чувствительность клеточного монослоя к действию протеаз. Вопросы мед. химии, 1995, 41, 6, 1922.</p><p>Серов В.В., Шехтер А.Б. Соединительная ткань, М. Медицина, 1981- 312.</p><p>Слуцкий Л.И. Биохимия нормальной и патологически измененной соединительной ткани. Л., Медицина, 1969, 375.</p><p>Стейси М. Баркер С. Углеводы живых тка- ней.-М., Мир, 1965, 324.</p><p>Andrews JL, Ghosh P, Lentini A. Temai B. The interaction of pentosan polysulphate with human neutrophil elastase and connective tissue matrix components, Chem. Biol. Interact, 1983. 47, 157-173.</p><p>Baici A, Salgani P, Fehr K, Boni A. Inhibition of human elastase from PMN leukocytes by glycosaminoglycan polysulphate (arteparon). Biochem. Pharmacol., 1980, 29, 1723-1727.</p><p>Bjelle A.O., Antonopoulos C.A., Engfeldt B. et al. Fractionation of the glycosaminoglycans of human articular cartilage on estiola cellulose in aging and in osteoarthrosis. Calcifid Tissue Res. 1972, 8, 3, 237-246.</p><p>Camejo G., Hurt-damejo E., Rosengren B. et al. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J. Lipid Res., 1991, 32, 1983-1991.</p><p>Campo R.D., Tourtellotte C.D. The composition of bovine cartilage and bone. Biochem. Bio- phys. Acta, 1967, 141, 3. 614-624.</p><p>Carreno MR, Muniz OE, Howell DS. The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental osteoarthritis: effect on morphological variables of disease severity. J. Rheumatol., 1986, 13, 490497,</p><p>Chvapil M. Physiology of connective tissue. Butterworths, London and Czechoslovak Medical Press, Prague, 1967, 417.</p><p>Conrozier T. Death of articular chondrocytes. Mechanisms and protection., Presse Med., 1998, 27,36, 1859-1861.</p><p>Conrozier T. Chondroitin sulfate (CS 4&amp;6): practical applications and economic impact. Presse Med., 1998, 27, 36, 1866-1868.</p><p>Deal CL., Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate and collagen hydrolysate. Rheum. Dis. Clin. North Am., 1999,25,2, 379-395.</p><p>Glade M.J. Polysulphated glucosaminoglycans accelerates net synthesis of collagen and glycosaminoglycan by arthritic equine cartilage tissues and chondrocytes. Am. J. Vet. Res., 1990, 51, 779-785.</p><p>Halverson P.B., Cheung H.S., Struve J., McCarty D.J. Suppression of active collagenase from calcified lapine synovium by arteparon. J. Rheumatol., 1987, 14, 1013-1017.</p><p>Hannan H., Ghosh P., Bellenger C., Taylor T. Systemic administration of glycosaminoglycan polysulphate (arteparon) provides partial protection of articular cartilage from damage produced by meniscectomy in the canine. J. Orthop. Res., 1987, 5, 47-59.</p><p>Hardingham T. Chondroitin sulfate and joint disease. Osteoarthritis Cartilage, 1998, 6, suppl A, 3-5.</p><p>Hardingham T. Proteoglycans. Biochem. Soc. Trans., 1981, 9, 6, 489-497.</p><p>Howell D.S. Pathogenesis of osteoarthritis. Am. J. Med. 1986, 80, 24-28.</p><p>Joint Cartilage Degradation. Basic and clinical aspects., Eds. Woessner J. F., Howell D.S., 1993, Marcel Dekker, Inc., NY-Basel-Hong Kong, 557.</p><p>Kalbhen D.A. Pharmacological studies on the anti-inflammatory effect of a semisynthetic polysaccharide (pentosan polysulfate). Pharmacology, 1973, 9, 74-79.</p><p>Kelly G.S. The role glucosamine sulfate and chondroitin sulfate in the treatment of degenerative joint disease. Alt. Med. Rev., 1998, 3, 1, 27-39.</p><p>Kingston A.E., Carney S.L., Hicks C.A, Bill- ingham M.E. In vitro and in vivo effects of proteoglycan fractions in adjuvant treated rats.- Agents Actions Suppl., 1993, 39, p. 75-79.</p><p>Konador A., Kawiak J. Changes in chondroitin sulfate concentration in rabbit blood plasma depending on the method of its administration.- Arch. Immunol. Therap. Experiment., 1977, 25, 895-903.</p><p>Kondo K., Seno N., Anno K. Mucopolysaccharides from chicken skin of three age groups,- Biochem. Biophys. Acta, 1971, 244, 3, 513-522.</p><p>Kontawelert P., Francis D.L., Brooks P.M., Ghosh P. Application of an enzyme- linked im- munosorbent-inhibition assay to quantitate the release of KS peptides into fluids of the rat subcutaneous air pouch model and the effects of chondroprotective drugs on the release process. Rheumatol Intern, 1989, 9, 77-83.</p><p>Van der Kraan P.M., de Vries B.J., Vitters E.L., et al. Inhibition of glycosaminoglycan synthesis in anatomically intact rat patellar by paracetamol-induced serum sulfate depletion. Biochem. Pharmacol., 1988, 37, 6, 3683-3690.</p><p>Van der Kraan P.M., Vitters E.L., de Vries B.J., van den Berg W.B. High susceptibility of human articular cartilage glycosaminoglycan synthesis to changes in inorganic sulfate availability. J. Orthop. Res., 1990, 8, 4, 565-571.</p><p>Lash J.W., Saxen L., Kosher R.A. Human chon- drogenesis: glycosaminoglycan content of embryonic human cartilage. J. Exp. Zool, 1974, 189, 1, 127-131.</p><p>Leeb B.F., Schweitzer H., Montag K., Smolen J.S. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J. Rheumatol., 2000, 27, 1, 205-211.</p><p>Lipson M.J., Cerskus R.A., Silbert J.E. Gly- cosaminoglycans and glycosaminoglycan-de- grading enzyme of Rana catesbeiana back skin during late stages of metamorphosis. Develop. Biol, 1971,25, 2, 198-208.</p><p>Lohmander S., Antonopoulos C.A., Friberg U. Chemical and metabolic heterogeneity of chondroitin sulfate and keratan sulfate in guinea pig cartilage and nucleus pulposus. Biochem. Bio- phys. Acta, 1973, 304, 2, 430-448.</p><p>Mankin H.J. Reaction of articular cartilage to injuiy and osteoarthritis. N. Engl. J. Med., 1974, 1310-1335.</p><p>Mathews B., Glagov S. Acid mucopolysaccharide patterns in development and aging of human and other vertebrate cartilage. In: Bioche- mie et physiologie du tissu conjonctif. Lyon, 1966, 21-26.</p><p>Meaney M.F. Increased accuracy and precision in screening for urinary mucopolysaccharides,- N. Z. J. Med. Lab. Technol, 1974, 28, 2, 29-34.</p><p>Muller W., Panse P., Brand S., Strubb A. In vivo study of the distribution, affinity for cartilage and metabolism of arteparon. Z. Rheumatol., 1983, 42, 355-361.</p><p>Murata K. Effect of age on distribution of acidic glycosaminoglycans in normal human urine: special reference to proportion of chondroitin sulfate A to the C-isomer. Experientia. 1973, 29, 10, 1219-1221.</p><p>Omata Т., Segawa Y., Itokazu Y. et al. Effects of chondroitin sulfate-C on bradykinin- induced proteoglycan depletion in rats. Arzneimittelfor- schung., 1999. 49, 7, 577-581.</p><p>Plaas A.H.K., West L.A., Wong-Palm S., Nelson F.R.T. Glycosaminoglycan sulfation in human osteoarthritis. Disease-related alterations at the non-reducing termini of chondroitin and dennatan sulfate. J. Biol. Chem., 1998, 273, 20, 12642-12649.</p><p>Postmen 0., Forsskahl B., Markhind M. Local glycosaminoglycan polysulphate injection therapy in osteoarthritis of the hand. A placebo controlled double-blind clinical study. Scand. J. Rheumatol., 1988, 17, 197-202.</p><p>Prodi G. Data on dermis mucopolysaccharides and their evolution in growing animals. In: Bio- chemie et physiologie du tissu conjonctif. Lyon, 1966, 33-39.</p><p>Ronca F., Palniieri L., Panicucci P., Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage, 1998, 6, suppl A, 14-21.</p><p>Setnikar I., Pacini M.A., Revel L. Antiarthritic effect of glucosamine sulfate studied in animal models. Arzneim. Forsch, 1991, 41, 542-545.</p><p>Setnikar I. Antireactive properties of “chondro- protective" drugs. Int. J. Tissue React., 1992, 41, 253-261.</p><p>Stanescu V., Stanescu R., Maroteaux P. Chemical studies on the human growth cartilage in fetuses and newborns. Biol. Neonate, 1973, 23, 5-6, 432-445.</p><p>Sugiura N., Iwasaki S., Aoki S. et al. Suppression of pannus-like extension of synovial cells by lipid-derivatized chondroitin sulfate: in vitro and in vivo studies using Escherichia coli- induced arthritic rabbits. Int. J. Exp. Pathol., 1995,76,5, 369-379.</p><p>Verbruggen G., Veys E.M. Influence of sulphat- ed glycosaminoglycans upon proteoglycan metabolism of synovial lining cells. Acta Rheumatol. Beig., 1977, 1, 75-92.</p></div><br />